Strengthening Investor Engagement and Driving Fundraising Success for a Biotech Company

Remediiate is a cleantech company that worked with NovAzure, who helped refine their positioning, develop a compelling equity story, and align stakeholders to drive an effective fundraising process.

Whatsapp Email

Intro


Remediiate is a startup that converts Industrial CO2 emission into Animal Feed.

They have developed a set of proprietary technology and know-how which distinguish them against the competition, having a first commercial scale installation at a Vale site in the UK (Nickel Refinery), in partnership with Forfarmers, an animal feed company.   

“I really liked how NovAzure worked with us and helped us strengthen our company. They are now part of Remediiate Story“

How We Helped


Remediiate enlisted NovAzure as their exclusive advisor for their equity raise.

With X-Ray investability assessment, NovAzure identified key areas for improvement before initiating the fundraising process and collaborated with Remediiate to implement these changes.

NovAzure conducted interviews with external stakeholders to ensure all critical perspectives were incorporated. Moreover, NovAzure managed the market research, helped develop financial models, crafted the pitch deck, Investment Memorandum, and assembled the Data Room.

Additionally, NovAzure performed a detailed valuation assessment to strengthen Remediiate’s position and devised a targeted fundraising strategy, identifying key investors.

The Value We Created


NovAzure successfully addressed all the necessary improvements in Remediiate’s company positioning to ensure impactful engagement with investors.

We developed a compelling equity story and valuation, aligning both internal and external stakeholders behind it. With everyone on board, NovAzure is now actively driving the ongoing fundraising process.